Then, the researchers went on to identify if these factors could be used to determine outcomes like 5-year cumulative incidence of relapse (CIR), overall survival (OS), leukemia-free survival (LFS), ...

Predictors of outcomes for patients undergoing autologous hematopoietic stem cell (HSC) transplantation for aggressive relapsed NHL are only partially known. In a reanalysis of the Parma trial, ...

Leukemia is a group of blood cancers that affects thousands of people worldwide. However, with advances in medicine, several different types of leukemia can be effectively treated with donor stem ...

Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials One hundred ...